The Practitioner's Guide to Psychoactive DrugsEllen L. Bassuk, Stephen C. Schoonover, Alan J. Gelenberg Books, like people, are born, and, if they survive the trauma of birth, mature in response to a changing environment. This volume is no exception. It imme diately proved its usefulness to psychiatric clinicians upon its publication six years ago, and it is not surprising to find it now entering a new phase of life in a second edition. The many and significant changes that the reader will find herein reflect not only the rapid growth of knowledge in the field of psy chopharmacology but also the editors' wise awareness of the need to incorpo rate that knowledge into clinical practice. Important new sections have been added on the management of elderly patients, on the pharmacological approach to those with temporal lobe epilepsy, and on the use of psychoactive medications during pregnancy. The existing clinical sections have been expanded, and the format has been altered to make the volume more practi cally useful for the harried clinician. Most important of all, the discussions of individual drugs have been carefully revised to update information about those medications that have stood the test of time and to include those newer pharmacological agents that have appeared on the clinical scene since the publication of the first edition. This last task has been significantly aided by the addition of Dr. Alan J. Gelenberg to the family of editors; his clinical and scientific knowledge nicely complements that of Drs. Bassuk and Schoonover, and its influence is evident throughout. |
Contents
The Practice of Pharmacotherapy | 1 |
General Clinical Guidelines | 8 |
Conclusion | 18 |
General Therapeutic Measures | 29 |
7 | 44 |
B Monoamine Oxidase Inhibitors | 57 |
13 | 59 |
Bipolar Affective Disorder and Recurrent Unipolar Depression | 79 |
Abuse of Central Nervous System Depressants | 235 |
Alcohol Abuse | 244 |
Geriatric Psychopharmacology | 293 |
Clinical Application | 305 |
Pediatric Psychopharmacology | 313 |
Depressive Episodes in Bipolar Affective Disorders | 317 |
Depression | 322 |
School Refusal | 328 |
Psychoses | 115 |
Conclusion | 163 |
Differential Diagnosis | 171 |
Clinical Use of Antianxiety Agents | 193 |
Summary | 199 |
Hypnotic Drugs | 205 |
Substance Abuse | 221 |
Evaluation of the Depressed Patient | 223 |
Other editions - View all
Common terms and phrases
acute addition administered adverse reactions affective disorders alcohol amitriptyline amphetamine antianxiety anticholinergic antihistamine antiparkinson antipsychotic agents antipsychotic drugs anxiety Arch Gen Psychiatry barbiturates behavior benzodiazepines bipolar blood levels brain cardiac cause central nervous system chlordiazepoxide chlorpromazine chronic clinical effects clinician CNS depressants cocaine decreased develop diazepam discontinued disease dopamine dosage dose Drug Abuse elderly episodes excretion extrapyramidal fluphenazine Gelenberg glutethimide half-life haloperidol heterocyclic heterocyclic antidepressants hyperactivity hypnotic hypotension imipramine impaired increased individuals ingestion insomnia interactions intoxication intravenous lithium liver maintenance mania manic maprotiline marijuana medication metabolism methadone methylphenidate monitor mood occasionally occur opiate oral overdose patients pharmacological pharmacotherapy phenobarbital phenothiazines phenytoin physical dependence physician plasma pregnancy produce propranolol Psychiatry psychosis psychotherapy psychotic psychotropic drugs receptors response result schizophrenic sedation sedative seizures severe sleep stimulation symptoms syndrome tardive dyskinesia therapeutic thioridazine tion tolerance toxicity trazodone treat treatment tremor unwanted effects urine users usually weeks withdrawal